Nimodipine, a calcium channel blocker initially manufactured and marketed for the treatment of hypertension, is also used in preventing vasospasm secondary to subarachnoid hemorrhage (a type of cerebral hemorrhage). Nimodipine comes under the brand called Nimotop. The global Nimodipine market is expected to grow at a CAGR of xx% during the forecast period 2021-2027.
The prominent Nimodipine market players operating globally include Bionpharma, Sun Pharm Inds, Sofgen pharms, Arbor Pharms, Bayer Vital GmBH and heritage Pharms. Additionally, market drivers associated with the growth of Global Nimodipine market are basically, price analysis, consumption, import/ export analysis, market estimates, raw material costs, location and quantity of product and up & down value chain analysis. Another market driver contributing to the growth of Nimodipine market includes gradual rise in the cases of cerebral hemorrhage and high blood pressure. With the increasing cases of such conditions, the demand for Nimodipine drug is anticipated to increase.
Geographically the region covered by the market across the globe include Europe (UK, Italy, France, Turkey, Germany and Russia), Middle East and Africa (Egypt, Nigeria, Saudi Arabia, South Africa and UAE), North America (Mexico, United States and Germany), South America ( Columbia, Argentina etc).
Marketing strategies followed by the global market players include value chain analysis and opportunity analysis. They analyze internal firm activities that add values to the product and to the market concerning cost and advantage. On the other hand, opportunities analysis mainly focuses on potential opportunity, strength and weakness for internal and external growth.
Market Coverage
o By Type
o By Application
Key questions addressed by the report
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
Global Nimodipine Market Report Segment
By Type
o Capsule
o Solution
o Tablets
By Application
o Hospital
o Pharmacy
o Clinics
Global Nimodipine Market Report Segment by Region
North America
Europe
Asia-Pacific
Rest of the World